Skip to content

Magnesium suplphate in protection against brain injury in newborn

Combined neuroprotective effect of magnesium sulfate plus therapeutic hypothermia versus therapeutic hypothermia alone in the management of term and near term infants with hypoxic ischaemic encephalopathy An open labelled randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/015057
Enrollment
40
Registered
2018-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hypoxic Ischemic Encephalopathy

Interventions

Intervention1: Term newborns with birth asphyxia meeting inclusion criterias.: They will receive therapeutic hypothermia same as the comparator group plus three intra-venous doses of magnesium sulphat

Sponsors

Pt B D sharma health university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A) Essential criterias : ( all three criterias should be met ) 1. Infants of more than 36 weeks of gestational period. 2. Admitted to NICU within 6 hrs of birth. 3. Birth weight more than 2000gm. B) Evidence of birth asphyxia ( any one of the following should be met ) 1. Apgar score less than 5 at 5 minutes after birth due to birth asphyxia/perinatal depression. 2. Continued need for resuscitation, including endotracheal or mask ventilation at 5 minutes after birth. 3. Acidosis within 60 minutes of birth defined as any occurrence of umbilical cord/arterial capillary pH less than 7.00 4. Base deficit more than 16 mmol/l in umbilical cord or any blood sample taken within 60 minutes of birth C) Evidence of encephalopathy ( any one of the following should be met ) 1. Clinical seizures 2. Evidence of moderate to severe encephalopathy, consisting of altered state of consciousness including lethargy, stupor or coma and at least one of the following; a. Hypotonia b. Abnormal reflexes including occulomotor or pupillary reflexes c. Absent or weak suck

Exclusion criteria

Exclusion criteria: 1. Babies with gross congenital malformation. 2. Treatment of mother with magnesium sulphate for pregnancy induced hypertension. 3. Babies with little chance to survive.( Apgar score less than 1 at 10 minutes ) 4. Infants received after 6 hrs of birth.

Design outcomes

Primary

MeasureTime frame
Combined outcome of mortality or abnormal neurological examination at time of dischargeTimepoint: Discharge

Secondary

MeasureTime frame
Abnormal MRI findingTimepoint: one month;abnormal neurological examinationTimepoint: one month

Countries

India

Contacts

Public ContactDr Geeta Gathwala

Pt B D Sharma PGIMS Rohtak

geetagathwala@gmail.com9896489650

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026